Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists
ClinicalTrials.gov · NCT04184947 · Registry updated: 2020-03-11
- Condition / research focus
- Type 2 Diabetes
- Sponsor
- University of Padova
- Countries with listed sites
- Italy
- Registry dates and results
- Start: 2014-03-01. Completion: 2020-02-29 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- SGLT2 inhibitor (drug)
- GLP-1 receptor agonist (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Division of Metabolic Diseases, University Hospital of Padova
Padova, Italy
Site recruitment: Not reported